• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

含甲氧苄啶的局部用溶液治疗眼表细菌感染的临床比较

Clinical comparison of topical solutions containing trimethoprim in treating ocular surface bacterial infections.

作者信息

Foulks G N, Austin R, Knowlton G

机构信息

Duke University Eye Center, Durham, North Carolina.

出版信息

J Ocul Pharmacol. 1988 Summer;4(2):111-5. doi: 10.1089/jop.1988.4.111.

DOI:10.1089/jop.1988.4.111
PMID:3049861
Abstract

Thirty-nine patients with bacterial ocular surface infections (conjunctivitis, blepharitis or blepharoconjunctivitis) were evaluated after treatment with a topically applied ophthalmic solution containing trimethoprim. A combination of trimethoprim and polymixin B (TP) produced identical clinical and microbiologic responses when compared to a solution containing, in addition to trimethoprim and polymyxin B, sulfacetamide. The sulfa component was not essential to produce desired clinical and microbiologic results.

摘要

39例细菌性眼表感染(结膜炎、睑缘炎或睑结膜炎)患者在使用含甲氧苄啶的局部应用眼科溶液治疗后接受了评估。与除甲氧苄啶和多粘菌素B外还含有磺胺醋酰的溶液相比,甲氧苄啶和多粘菌素B的组合(TP)产生了相同的临床和微生物学反应。磺胺成分对于产生理想的临床和微生物学结果并非必不可少。

相似文献

1
Clinical comparison of topical solutions containing trimethoprim in treating ocular surface bacterial infections.含甲氧苄啶的局部用溶液治疗眼表细菌感染的临床比较
J Ocul Pharmacol. 1988 Summer;4(2):111-5. doi: 10.1089/jop.1988.4.111.
2
Clinical evaluation of trimethoprim-containing ophthalmic solutions in humans.
Am J Ophthalmol. 1984 Jul 15;98(1):11-6. doi: 10.1016/0002-9394(84)90181-8.
3
Trimethoprim-polymyxin B ophthalmic solution in treatment of surface ocular bacterial infections.
Ann Ophthalmol. 1985 Dec;17(12):746-8.
4
A double-blind comparative study of trimethoprim-polymyxin B versus trimethoprim-sulfacetamide-polymyxin B otic solutions in the treatment of otorrhea.甲氧苄啶-多粘菌素B与甲氧苄啶-磺胺醋酰-多粘菌素B耳用溶液治疗耳漏的双盲对照研究。
J Laryngol Otol. 1981 Mar;95(3):251-9. doi: 10.1017/s002221510009068x.
5
[Double-blind comparative trial of trimethoprim-polymyxin B and trimethoprim-sulphacetamide-polymyxin B ear drops in the treatment of otorrhoea (author's transl)].甲氧苄啶-多粘菌素B与甲氧苄啶-磺胺醋酰-多粘菌素B耳滴剂治疗耳漏的双盲对照试验(作者译)
Ann Otolaryngol Chir Cervicofac. 1981;98(1-2):37-40.
6
Comparison of three topical antimicrobials for acute bacterial conjunctivitis.
Pediatr Infect Dis J. 1988 Sep;7(9):626-9. doi: 10.1097/00006454-198809000-00005.
7
Polytrim eyedrops.聚三甲铵乙内酯眼药水
Drug Ther Bull. 1988 May 31;26(11):43-4.
8
Trimethoprim-polymyxin B ophthalmic solution in the treatment of presumptive bacterial conjunctivitis--a multicentre trial of its efficacy versus neomycin-polymyxin B-gramicidin and chloramphenicol ophthalmic solutions.甲氧苄啶-多粘菌素B眼药水治疗疑似细菌性结膜炎——与新霉素-多粘菌素B-短杆菌肽及氯霉素眼药水疗效对比的多中心试验
J Antimicrob Chemother. 1983 Mar;11(3):217-21. doi: 10.1093/jac/11.3.217.
9
A multicenter comparison of polymyxin B sulfate/trimethoprim ophthalmic solution and moxifloxacin in the speed of clinical efficacy for the treatment of bacterial conjunctivitis.硫酸多粘菌素B/甲氧苄啶滴眼液与莫西沙星治疗细菌性结膜炎临床疗效速度的多中心比较
J Pediatr Ophthalmol Strabismus. 2008 Nov-Dec;45(6):340-9. doi: 10.3928/01913913-20081101-07.
10
Trimethoprim-polymyxin ophthalmic solution versus chloramphenicol ophthalmic solution in the treatment of bacterial conjunctivitis.
Pharmatherapeutica. 1982;3(4):274-7.

引用本文的文献

1
Interventions for chronic blepharitis.慢性睑缘炎的干预措施。
Cochrane Database Syst Rev. 2012 May 16;2012(5):CD005556. doi: 10.1002/14651858.CD005556.pub2.
2
Acute infectious conjunctivitis in childhood.儿童急性感染性结膜炎
Paediatr Child Health. 2001 Jul;6(6):329-35. doi: 10.1093/pch/6.6.329.
3
Is ophthalmology evidence based? A clinical audit of the emergency unit of a regional eye hospital.眼科是基于证据的吗?对一家地区眼科医院急诊科的临床审计。
Br J Ophthalmol. 2003 Apr;87(4):385-90. doi: 10.1136/bjo.87.4.385.